Atralin

mottled hyperpigmentation, Alopecia, Hyperpigmentation + 14 more

Treatment

2 FDA approvals

16 Active Studies for Atralin

What is Atralin

Tretinoin

The Generic name of this drug

Treatment Summary

Tretinoin, also known as all-trans-retinoic acid (ATRA), is a derivative of Vitamin A. It helps to regulate cell activity, including reproduction, growth, and differentiation. Tretinoin is commonly used to treat acne, sun damage, and skin conditions such as ichthyosis and keratosis follicularis. It also has anti-cancer properties and is used in the treatment of acute promyelocytic leukemia (APL).

Tretinoin Cream

is the brand name

Atralin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Tretinoin Cream

Tretinoin

1973

185

Approved as Treatment by the FDA

Tretinoin, also known as Tretinoin Cream, is approved by the FDA for 2 uses including Alopecia and Alopecia .

Alopecia

Used to treat Alopecia in combination with Minoxidil

Alopecia

Used to treat Alopecia in combination with Minoxidil

Effectiveness

How Atralin Affects Patients

Tretinoin is a form of vitamin A that helps to regulate how the cells in our body reproduce, multiply, and change. It is used to treat acne, wrinkles, and other skin conditions, as well as a type of cancer called acute promyelocytic leukemia (APL).

How Atralin works in the body

Tretinoin works by targeting certain receptors in your cells. These receptors are associated with the development of certain cancers and the effects of tretinoin on skin and bones. The main way tretinoin helps to treat acne is by changing how the skin cells behave. It helps to decrease the number of cells that stick together, allowing the skin to shed the extra cells and prevent the formation of microcomedos, which are the precursors of acne. Tretinoin also helps with a type of blood cancer called acute promyelocytic leukemia. It causes immature blood cells to mature, which can lead to complete

When to interrupt dosage

The measure of Atralin is contingent upon the diagnosed malady, including Alopecia, Chloasma and Chloasma. The amount likewise fluctuates as per the technique of delivery featured in the table beneath.

Condition

Dosage

Administration

Fine Wrinkles

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

mottled hyperpigmentation

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Alopecia

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Hyperpigmentation

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

tactile roughness of facial skin

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

severe, recalcitrant Cystic acne

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Acute Promyelocytic Leukemia

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Chloasma

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Chloasma

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Dermatologic disorders

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Acne Vulgaris

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

benzyl violet

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

sun avoidance program

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Skin

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

sun avoidance measures

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Hand

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

keratinization disorders of the feet

, 0.0005 mg/mg, 0.001 mg/mg, 0.00025 mg/mg, 0.000375 mg/mg, 0.00075 mg/mg, 0.0001 mg/mg, 0.0002 mg/mg, 0.00005 mg/mg, 0.000025 mg/mg, 0.0004 mg/mg, 0.4 mL/mg, 0.001 mL/mg, 10.0 mg, 0.00001 mg/mg, 0.1 %, 0.025 %, 0.05 %, 0.01 %, 0.04 %, 0.00004 mg/mg, 0.0008 mg/mg, 0.1 mg/mL, 0.0006 mg/mg, 2.5 mg/mg, 0.5 mg/mL, 0.0025 mg/mg, 0.000015 mg/mg, 0.0000075 mg/mg

, Gel, Gel - Topical, Topical, Cream - Topical, Cream, Kit, Oral, Capsule - Oral, Capsule, Liquid, Liquid - Topical, Solution - Topical, Solution, Capsule, liquid filled, Capsule, liquid filled - Oral, Emulsion, Lotion, Lotion - Topical, Emulsion - Topical, Kit - Topical

Warnings

Atralin Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Tretinoin may interact with Pulse Frequency

There are 20 known major drug interactions with Atralin.

Common Atralin Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Tretinoin is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Tretinoin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abetimus

Major

The risk or severity of adverse effects can be increased when Tretinoin is combined with Abetimus.

Acteoside

Major

The risk or severity of adverse effects can be increased when Tretinoin is combined with Acteoside.

Aldosterone

Major

The risk or severity of adverse effects can be increased when Tretinoin is combined with Aldosterone.

image of a doctor in a lab doing drug, clinical research

Atralin Novel Uses: Which Conditions Have a Clinical Trial Featuring Atralin?

65 active studies are currently assessing the potential of Atralin in the management of Chloasma, Acne and Alopecia.

Condition

Clinical Trials

Trial Phases

Chloasma

0 Actively Recruiting

Alopecia

14 Actively Recruiting

Early Phase 1, Not Applicable, Phase 3, Phase 2, Phase 1

mottled hyperpigmentation

0 Actively Recruiting

severe, recalcitrant Cystic acne

0 Actively Recruiting

keratinization disorders of the feet

0 Actively Recruiting

tactile roughness of facial skin

0 Actively Recruiting

Skin

0 Actively Recruiting

Dermatologic disorders

0 Actively Recruiting

Hyperpigmentation

0 Actively Recruiting

Fine Wrinkles

0 Actively Recruiting

Hand

0 Actively Recruiting

Chloasma

0 Actively Recruiting

sun avoidance measures

0 Actively Recruiting

Acute Promyelocytic Leukemia

0 Actively Recruiting

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

benzyl violet

0 Actively Recruiting

sun avoidance program

0 Actively Recruiting

Atralin Reviews: What are patients saying about Atralin?

5

Patient Review

12/28/2012

Atralin for Acne

This medication has been a godsend for my adult acne. In just two weeks of using it every night, my acne is almost completely gone!

5

Patient Review

3/26/2013

Atralin for Acne

I had small cysts near my mouth, and sometimes on my cheeks. I'm 50 years old, so you can imagine my delight when not only did this treatment clear the bumps, but it also got rid of wrinkles and evened out my skin tone! I'll use it forever - just wish it were sold over the counter.

5

Patient Review

11/13/2013

Atralin for Acne

I tried this gel on a recommendation, but it completely dried out the area around my mouth and nose. It looked like I had burned my skin. However, I was told this was normal so I tried it one more time. And it BURNED my skin now--to the point where it looks like I have a busted lip.

5

Patient Review

5/3/2019

Atralin for Acne

Atralin was a complete lifesaver for my acne. It took a few weeks for the full effects to be visible, and the initial period where my skin was red and itchy was tough to get through. But it was so worth it in the end, and I would highly recommend this medication to anyone struggling with acne.

5

Patient Review

3/1/2015

Atralin for Acne

This treatment is amazing for acne! It cleared up my skin within a week and it's been smoother than ever since. It can be a bit drying, but as long as you use a face oil on top (like the doctor recommended), it doesn't affect the drug's effectiveness.

5

Patient Review

12/8/2009

Atralin for Acne

5

Patient Review

5/31/2012

Atralin for Acne

Initially, my skin felt terrible after using this product. There was a bad breakout on my chin area. However, after a few weeks my skin started to feel smoother and the acne gradually calmed down. I've been using the treatment for 12 weeks now and my skin has cleared up significantly; though there is some stinging and drying side effects.

4.3

Patient Review

3/31/2012

Atralin for Acne

I use this acne treatment about two to three times a week, as necessary. It's very effective at making blemishes disappear and my skin looks so much healthier overall.

4

Patient Review

9/9/2010

Atralin for Acne

I've only been using this product for a little over a week, but I'm already in love. My previous medication made my breakouts worse, but this one has cleared up my skin completely. Not to mention, it also seems to be working on fine wrinkles! So far the only downside is that it makes my skin dry and peel, which is a small price to pay for how well it works.

3

Patient Review

11/18/2010

Atralin for Acne

Yes, your face will dry out when you first start using it. However, this only lasts for a few days and then goes away. For most people, pimples will be gone within a week to two weeks.

2

Patient Review

6/21/2011

Atralin for Acne

This gel has been great for reducing the redness and size of my pores. I have very sensitive skin, but this medication didn't cause any problems. The downside is that it can make your skin flake a bit, but a good moisturizer takes care of that. And at $260 per tube, it's not cheap! Luckily my HMO covers it.

2

Patient Review

10/13/2011

Atralin for Acne

I've been using this medication for a couple of months now with zero improvement in my acne. If anything, it's gotten worse. I have used other treatments in the past that took some time to work but eventually did show signs of improvement; Benzaclin was one such treatment that was actually effective.

1.7

Patient Review

1/1/2017

Atralin for Acne

Atralin unfortunately made my acne worse. I had moderate acne to begin with, but after using this product my skin condition has deteriorated significantly. It's now difficult for me to even look in the mirror, and my skin is permanently irritated. If you're considering this treatment, be aware of the risks involved.

Patient Q&A Section about atralin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Atralin good for wrinkles?

"Atralin is a retinoid used to treat acne vulgaris. It can also be used to improve the appearance of rough skin, fine wrinkles, and abnormal skin pigmentation caused by sun damage. It works by affecting skin cell growth."

Answered by AI

What ingredients are in Atralin?

"The inactive ingredients of Atralin are benzyl alcohol, butyl paraben, butylated hydroxytoluene, carbomer 940, ethyl paraben, fish collagen hydrolyzates, glycerin, iso-butyl paraben, methylparaben, octoxynol 9, phenoxyethanol, propylparaben, purified water, sodium hyaluronate, and trolamine."

Answered by AI

What is Atralin used for?

"This acne medication decreases the number and severity of pimples and promotes quick healing. Tretinoin belongs to a class of medications called retinoids."

Answered by AI

Is Atralin A retinoid?

"Atralin is a medication used to treat acne. It is a type of retinoid, which is a group of medications that work by affecting the growth of skin cells."

Answered by AI

Clinical Trials for Atralin

Image of Advanced Dermatology & Cosmetic Surgery in Maitland, United States.

Xtresse Serum for Hair Loss

18 - 65
All Sexes
Maitland, FL

The goal of this study is to determine how safe and effective it is to improve hair growth by applying a serum daily on the scalp of men and women with thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily usage of Xtressé serum. Participants who qualify will complete 4 visits after voluntary consent has been given. Participants will be given 4 bottles of serum to use during the study. The product will be applied daily over a 4-month period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth. Participants will complete a survey at the end of the study.

Waitlist Available
Has No Placebo

Advanced Dermatology & Cosmetic Surgery (+2 Sites)

Melissa Rayner, MS

Restore Biologics Holdings, Inc. dba Xtressé

Image of Advanced Dermatology & Cosmetic Surgery in Maitland, United States.

Xtressé Gummies for Alopecia

18 - 65
Female
Maitland, FL

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in women with self-perceived thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 5 visits after voluntary consent has been given. Participants will be given a 30-day supply of the gummies at each visit over a 4-month period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Waitlist Available
Has No Placebo

Advanced Dermatology & Cosmetic Surgery (+3 Sites)

Melissa Y Rayner, MS

Restore Biologics Holdings, Inc. dba Xtressé

Image of Advanced Dermatology & Cosmetic Surgery in Maitland, United States.

XVIE for Alopecia

28 - 65
Female
Maitland, FL

The goal of this study is to determine how safe and effective it is to improve hair growth using XVIE solution applied on the scalp of women with self-perceived thinning hair. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. Participants who qualify will complete 5 to 6 visits after voluntary consent has been given. Participant's scalp will be numbed and the XVIE solution will be applied by microneedling. Photographs will be taken at each visit to measure changes in hair volume, thickness, and growth. Every participant will receive active treatment twice over the 4 month period.

Waitlist Available
Has No Placebo

Advanced Dermatology & Cosmetic Surgery (+1 Sites)

Melissa Y Rayner, MS

Restore Biologics Holdings, Inc. dba Xtressé

Have you considered Atralin clinical trials?

We made a collection of clinical trials featuring Atralin, we think they might fit your search criteria.
Go to Trials
Image of Skin Wellness Dermatology in Birmingham, United States.

Xtressé Supplement and Serum for Alopecia

28 - 65
Female
Birmingham, AL

The goal of this clinical trial is to test how safe and effective it is to improve hair growth using an active gummy and serum combination treatment when compared to an inactive treatment combination in women with self-perceived thinning hair. The main questions this trial aims to answer are: * to confirm using photograph analytics, how much hair growth has increased in a marked area when using active treatment versus inactive treatment, and * participants assessment and satisfaction with the hair growth using scaled assessments. Participants who qualify will be asked to complete 6 to 7 visits after voluntarily consent has been given. The study is divided into two parts. In Part A participants will be randomly given either active or inactive treatment to use over 3 months. After 3 months, all participants will enter Part B of the study and will be given active treatment to use over the final 6 months of the study.

Recruiting
Paid Trial

Skin Wellness Dermatology (+1 Sites)

Danielle Leavitt

Restore Biologics Holdings, Inc. dba Xtressé

Image of Marc Avram MD in New York, United States.

TargetCool + Benev Exosomes for Alopecia

18 - 70
All Sexes
New York, NY

This clinical trial is testing a new approach to help improve hair thinning using a combination of cosmetic treatments. The purpose of the study is to learn whether applying exosomes to the scalp, along with microneedling and a precision cooling device called TargetCool™. This study aims to determine whether this combination approach offers synergistic benefits for individuals with hair thinning. Exosomes are tiny particles that come from stem cells and contain growth factors and other nutrients. They are being studied for their potential to help regenerate skin and hair. TargetCool™ is an FDA-cleared device that uses precision cooling to reduce inflammation and improve comfort. Microneedling is a common, minimally invasive procedure that uses small needles to stimulate the skin and help absorb topical products more effectively. The study will include healthy men (ages 18 to 70) and women (ages approximately 45 to 70) who are not of childbearing potential. A total of 9 to 15 participants will be randomly placed into one of three groups: Group 1: Exosomes with TargetCool™ Group 2: Microneedling followed by exosomes and TargetCool™ Group 3: Microneedling followed by exosomes only Participants will receive four treatments over 9 weeks. Each visit may include microneedling, TargetCool™ treatment, and exosome application depending on group assignment. A small tattoo will be placed on the scalp to help capture consistent photographs, and a special imaging system (Canfield HairMetrix®) will be used to measure hair changes. Participants will return for follow-up visits at 3 and 6 months after the final treatment. The results will help determine whether this combination of cosmetic treatments is safe and beneficial for people experiencing hair thinning.

Waitlist Available
Has No Placebo

Marc Avram MD

Dawn Queen, MD

Recens Medical, Inc.

Have you considered Atralin clinical trials?

We made a collection of clinical trials featuring Atralin, we think they might fit your search criteria.
Go to Trials

Have you considered Atralin clinical trials?

We made a collection of clinical trials featuring Atralin, we think they might fit your search criteria.
Go to Trials